ICRC IDC Non-CDC Study Supplement

Injury Control Research Centers (ICRC) Indicators Data Collection 20XX – Non-CDC Study Supplement

Form Approved

OMB No.: 0920-xxxx

Expiration Date: XX/XX/XXXX

Public Reporting burden of this collection of information is estimated at 5 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NW, MS D-74, Atlanta, GA  30333; Attn:  PRA (0920-XXXX).

Awardee      

FOA Number      

Instructions

Please refer to the companion ICRC indicator template guidance document for instructions on completing this template.

Utilize this spell check button in order to spell check the document.

3. Completed and Ongoing Studies: Non-CDC Funded

Studies supported with ICRC funding, ICRC supported personnel, or other funding. These studies are in addition to the CDC supported studies identified in the main ICRC Data Collection Document.

Study 1

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 2

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 3

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 4

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 5

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 6

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 7

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 8

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 9

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 10

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 11

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 12

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 13

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 14

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 15

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 16

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 17

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 18

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 19

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 20

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 21

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 22

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 23

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 24

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 25

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 26

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 27

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 28

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 29

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 30

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 31

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 32

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 33

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 34

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 35

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 36

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 37

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 38

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 39

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 40

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 41

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 42

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 43

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 44

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 45

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 46

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 47

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 48

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 49

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

Study 50

Study Title (500 Character Limit)      

ICRC Personnel Involved (500 Character Limit)      

Principal Investigator (255 Character Limit)      

Partners Involved in Study (1000 Character Limit)      

Project Start Date      

Project End Date      

Injury Topic Area: Primary: Secondary: Tertiary:

If "Other" please describe (500 Character Limit)      

Brief Summary/Results (1000 Character Limit)      

Implications of Findings for Practice:      

Plans for Use/Outreach of Study Findings      

Type of Research or Evaluation (Select all that apply)

Surveillance

Basic Epidemiology

Risk/Protective Factor Research

Intervention Research

Translational Research

Implementation Research

Policy Research or Evaluation

Economic/Cost-Effectiveness Evaluation

Other

If "Other" please describe (500 Character Limit)      

Level of Prevention

What additional information do you want to provide about completed and ongoing studies (e.g., cross-disciplinary nature of studies, innovative studies, how a study impacted the field, how studies related to your previous studies or planned future studies, etc.)? (There is no character limit for this response)

     

Other Significant Information

Describe any other proposed research-related objectives and activities for the budget year and any significant programmatic changes.